The Microchemistry and Proteomics Facility (MPF) supports laboratory and clinical research programs at MSKCC by (i) providing synthetic peptides and by (ii) performing mass spectrometric and amino acid sequence analyses of proteins and peptides, generally for the purpose of identification, relative quantitative analysis and post-translational modification (PTM) analysis. Synthetic molecules are made according to specifications provided by the investigator. Samples submitted for identification (either single proteins or mixtures), for PTM analysis or N-terminal sequencing are prepared by the lab requesting service. Information on chemistries and instrumentation, and expert advice on experimental approaches are provided by facility staff when needed. The goal of proteomics is to analyze changing levels, local concentrations and post-translational modifications of proteins in a cell, as well as to analyze higher-order networks of protein-protein interactions. Proteins and protein modifications are critical in the complex signaling pathways and regulatory processes underlying cell growth, division, differentiation, DNA repair, development, senescence, and in responses to bioactive agents, genetic alterations and disease. Dissection of multi-component protein complexes is therefore increasingly the focus of studies on molecular control mechanisms. Identification of unique components provides a powerful approach to the selective retrieval and identification of the companions. The impact that these services have provided, in facilitating research projects and enabling the timely progression of high priority research, can be recognized throughout the reports of the several research programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA008748-47S4
Application #
8602885
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-01-20
Project End
2014-12-31
Budget Start
2012-01-09
Budget End
2012-12-31
Support Year
47
Fiscal Year
2013
Total Cost
$338,597
Indirect Cost
$160,012
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Owen, Dwight; Chaft, Jamie E (2018) Immunotherapy in surgically resectable non-small cell lung cancer. J Thorac Dis 10:S404-S411
Gill, Samuel C; Lim, Nathan M; Grinaway, Patrick B et al. (2018) Binding Modes of Ligands Using Enhanced Sampling (BLUES): Rapid Decorrelation of Ligand Binding Modes via Nonequilibrium Candidate Monte Carlo. J Phys Chem B 122:5579-5598
Vorkas, Charles Kyriakos; Wipperman, Matthew F; Li, Kelin et al. (2018) Mucosal-associated invariant and ?? T cell subsets respond to initial Mycobacterium tuberculosis infection. JCI Insight 3:
Li, Xiang; Li, Tianfang; Yorke, Ellen et al. (2018) Effects of irregular respiratory motion on the positioning accuracy of moving target with free breathing cone-beam computerized tomography. Int J Med Phys Clin Eng Radiat Oncol 7:173-183
Jain, Devanshi; Puno, M Rhyan; Meydan, Cem et al. (2018) ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2. Elife 7:
Laird, James; Lok, Benjamin; Siu, Chun et al. (2018) Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy. Ann Surg Oncol 25:154-163
Leeman, Jonathan E; McBride, Sean M; Spielsinger, Daniel et al. (2018) Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks. Int J Cancer 142:2485-2490
Reiner, Anne S; Sisti, Julia; John, Esther M et al. (2018) Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 36:1513-1520
Bhatia, Ankush; Ulaner, Gary; Rampal, Raajit et al. (2018) Single-agent dabrafenib for BRAFV600E-mutated histiocytosis. Haematologica 103:e177-e180
Khalil, Danny N; O'Reilly, Eileen M (2018) Classification of Pancreatic Cancer: Ready for Practical Application? Clin Cancer Res 24:4355-4356

Showing the most recent 10 out of 8799 publications